Nov 21, 2018 FDA: Stopping Fingolimod May Exacerbate MS FDA: Stopping Fingolimod May Exacerbate MSMultiple sclerosis (MS) patients treated with fingolimod (Gilenya) may experience severe disease worsening when the drug is stopped, the FDA ... read morePublished on 2018-11-21